A “zero false positives” promise is credible only as a narrow statement about what reaches the final report after validation. It cannot guarantee that every security conclusion is permanently correct, that no environmental assumption is missing or that no dispute will occur. Ask for the operating process behind the claim: reproduction, evidence thresholds, peer review, severity calibration, uncertainty handling and correction.

The strongest provider does not eliminate uncertainty through marketing language. It makes uncertainty visible, distinguishes potential observations from validated findings and maintains a controlled way to revise conclusions when new facts emerge.

Define what the vendor calls a false positive

Ask whether the term means the vulnerable condition does not exist, the exploit is unreachable in production, the impact was overstated, a compensating control was missed or the finding cannot be reproduced. These are different quality issues and may require different resolution.

  • Tool alert rejected during triage.
  • Observable weakness without demonstrated security impact.
  • Confirmed vulnerability with disputed severity.
  • Valid finding on the test build but not on another environment.
  • Finding invalidated by previously unavailable evidence.

A provider should not use “false positive” to dismiss a valid weakness merely because the organization accepts the risk or deploys a compensating control.

Require manual reproduction before reporting

  1. Identify the exact target, build, role, tenant and state.
  2. Reproduce the suspected behaviour deliberately.
  3. Establish the expected secure outcome.
  4. Capture the request, response or equivalent technical evidence.
  5. Confirm security impact and practical preconditions.
  6. Check whether an active control changes the conclusion.
  7. Record limitations and unresolved assumptions.

Automated tools can generate useful hypotheses. The final report should not promote a tool signature to a confirmed finding without human validation and contextual evidence.

Set evidence thresholds by finding type

Different vulnerabilities require different proof. An authorization issue needs controlled actor and ownership evidence. Injection needs evidence that attacker-controlled data reached an interpreter with impact. Sensitive-data exposure needs the data class, access path and affected population. Business-logic abuse needs the violated invariant and workflow outcome.

  • Reproducible steps with safe preconditions.
  • Raw protocol or system evidence where applicable.
  • Positive control or comparison that rules out normal behaviour.
  • Observed impact separated from extrapolated impact.
  • Tester confidence and limitations for uncertain cases.

Use peer review before high-impact findings leave the team

Critical and high findings should receive an independent technical review. The reviewer should challenge reproduction, alternate explanations, scope, impact, severity, wording and redaction. Medium or unusual findings may also need review according to policy.

Ask how reviewer independence works, how disagreements are resolved and whether evidence is re-executed or only read. A signature alone does not show meaningful QA.

Calibrate severity separately from validity

A finding can be valid while its severity remains debatable. Require the vendor to preserve technical evidence and explain scoring inputs, environmental assumptions, blast radius and compensating controls. Adjusting priority or severity should not erase the underlying verified condition.

  • Technical vector and scoring method.
  • Privileges, interaction and exploit reliability.
  • Production reachability and data sensitivity.
  • Observed and maximum credible impact.
  • Attack chains and independent controls.

Create a category for inconclusive observations

Some hypotheses cannot be safely validated because a destructive action is prohibited, an integration is unavailable or evidence is incomplete. The vendor should label these as observations, limitations or follow-up items rather than forcing them into confirmed findings or silently discarding them.

State what was observed, what remains unknown, why validation stopped and which safe next step could resolve uncertainty.

Inspect the report quality process

  • Tester self-review against a required evidence checklist.
  • Technical peer review for reproduction and impact.
  • Editorial review for clarity, consistency and sensitive data.
  • Severity calibration across the report.
  • Final reconciliation of findings, coverage and limitations.
  • Controlled versioning and correction after delivery.

Ask for a redacted QA checklist or workflow. A credible process should leave traceable review evidence without disclosing other clients’ sensitive information.

Test the claim with a sample finding

Review a redacted example and ask a practitioner to explain how it moved from hypothesis to report. Look for the original signal, manual validation, evidence, rejected alternate explanation, reviewer challenge, severity reasoning and final wording.

Marketing personnel may accurately describe policy, but the practitioner explanation reveals whether the process operates in daily delivery.

Define the dispute and correction process

  1. Client identifies the contested fact or assumption.
  2. Vendor reproduces on the named environment and build.
  3. Both sides test the claimed control or condition.
  4. Vendor confirms, revises, downgrades or withdraws the finding with rationale.
  5. Report version and downstream artefacts are corrected.
  6. Root cause of the quality failure feeds process improvement.

A guarantee without a correction process encourages defensiveness. Quality is shown by how promptly and transparently the provider handles contradictory evidence.

Watch for red flags

  • All automated alerts are called findings.
  • Screenshots replace reproducible technical evidence.
  • No findings are ever revised after client review.
  • Severity disagreement is counted as proof of a false positive.
  • Unvalidated concerns are omitted without a limitations record.
  • The sales claim has no written definition or QA artefact.

Measure validation quality realistically

Track report corrections, withdrawn findings, evidence defects, severity changes, client reproduction success and recurring QA failures. Interpret the numbers with volume and complexity. A provider reporting zero corrections may have excellent validation, little transparency or weak feedback capture.

The testing and reporting discipline in NIST SP 800-115 supports evidence-based analysis and clear communication. Use those principles to evaluate the process behind any absolute quality claim.

Contract for process, not a slogan

  • Written definition of a reportable finding.
  • Minimum reproduction and evidence requirements.
  • Peer-review rules for consequential findings.
  • Treatment of uncertainty and limitations.
  • Response and correction expectations after challenge.
  • Retest evidence and final-status standards.

The practical decision

Accept “zero false positives” only as shorthand for a rigorous validation objective. Verify that every reportable finding is manually reproduced, evidenced, contextually assessed and peer-reviewed, with uncertain observations labeled and errors corrected transparently. The process is the assurance; the absolute phrase is not.

Review WIMD’s finding-validation approach including manual reproduction, evidence standards, peer review, severity calibration and transparent correction.